![]() |
|
|
Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA 92093-0901
3To whom correspondence and reprint requests should be addressed.
| ABSTRACT |
|---|
|
|
|---|
-carotene, lutein
and ß-cryptoxanthin at 12 mo (P < 0.05).
ß-Carotene,
-carotene and lutein intakes also were significantly
higher at 36 mo (P < 0.05). At 36 mo, the
intervention group had significantly higher plasma concentrations of
-carotene and ß-carotene compared with the control group.
Repeated-measures ANOVA revealed that the intervention group had
significantly increased (P < 0.05 with Bonferroni
correction) plasma ß-carotene,
-carotene, lutein and lycopene
concentrations at 12 and 36 mo compared with baseline. Baseline
carotenoid concentrations were significantly inversely predictive
(P < 0.05) of plasma carotenoid change. In
addition, change in body mass index (BMI) and plasma cholesterol
concentrations were predictive of plasma carotenoid change from
baseline to 3 y. Results of this study demonstrate that change in
plasma carotenoid concentrations is associated with change in BMI,
change in plasma cholesterol and baseline carotenoid concentrations.
Plasma carotenoid response can be an indicator of long-term high
vegetable intake for women at risk of breast cancer recurrence.
KEY WORDS: carotenoids biomarkers humans breast cancer
| INTRODUCTION |
|---|
|
|
|---|
Factors influencing bioavailability of carotenoids may affect plasma
carotenoid response. Dietary components such as fat and the matrix of
the food consumed may affect the absorption of carotenoids
(Olson 1994
, Parker 1997
, Rock 1997
) and plasma response. Fiber, another component of
vegetables and fruits, may interfere with micelle formation and thereby
reduce absorption of carotenoids, potentially influencing plasma
carotenoid response (Rock and Swendseid 1992
). The
transport of circulating carotenoids in plasma by cholesterol-rich
lipoproteins suggests that plasma lipids also may affect carotenoid
concentrations (Clevidence and Bieri 1993
).
Rock et al. (1992)
demonstrated that a reduction in
dietary consumption of vegetables and fruits is followed by a rapid
decrease in plasma carotenoid concentrations. Monitoring plasma
carotenoid concentrations may be useful in dietary intervention trials
examining the influence of vegetable and fruit consumption on disease
outcomes. Plasma carotenoids can function as biomarkers of vegetable
and fruit intake. The first aim of this study was to investigate plasma
carotenoid concentrations, dietary carotenoid consumption, and
vegetable and fruit intakes at baseline, 12 and 36 mo postrandomization
in postsurgically resected breast cancer patients participating in a
randomized feasibility study for a trial examining the effect of a high
vegetable and fruit diet on the recurrence of breast cancer. An
additional aim was to examine predictors of change in plasma carotenoid
concentrations from baseline to 36 mo postrandomization.
| MATERIALS AND METHODS |
|---|
|
|
|---|
This study examined the feasibility of a randomized diet intervention trial to reduce the risk of breast cancer recurrence in women who had been diagnosed with primary breast cancer within the previous 4 y. Between May 1993 and October 1994, 93 subjects were recruited from cancer registry lists and from community-based efforts. Inclusion criteria were as follows: 1) 1870 y of age at time of diagnosis; 2) a history of primary operable invasive breast carcinoma categorized as Stage I, Stage II or Stage IIIA within the previous 4 y; 3) treatment with total mastectomy and axillary dissection, or breast-sparing surgical removal of cancer with clear macroscopic margins and axillary dissection, followed by adjuvant breast radiation; 4) completion of any prescribed adjuvant chemotherapy; 5) no evidence of recurrent disease or new breast cancer since completion of initial local treatment; 6) in good general health; 7) accessible geographically and by telephone for participation and follow-up; and 8) able to communicate dietary data via 24-h food recall. Exclusion criteria were the following: 1) current enrollment in another dietary clinical trial; 2) diagnosed with a comorbidity requiring a specific diet or taking a medication that contraindicates a high fiber diet; 3) receiving estrogen replacement therapy; 4) other primary or recurrent invasive cancer within the last 10 y; and 5) unable to commit to the intervention schedule.
Within the 1st y of the feasibility study, a total of 10 women dropped out (4 from the intervention group; 6 from the control group). Seven women experienced a recurrence of breast cancer before the 12-mo data collection point. An additional five did not complete their 12-mo assessments, although they remained in the study. Initially, the pilot study was scheduled to end within 1 y of randomization; however, consent for continued participation was requested from the women after the 1st y so that they could participate in the remaining 7 y of the clinical trial. Seventy women elected to continue at the end of the 1st y. Of these 70 women, three experienced breast cancer recurrence before 36 mo; nine did not complete dietary recalls at 36 mo, but were still in the study; one did not have dietary data at all three time points; and one died before 36 mo. For the clinic visits necessary for blood collection, eight did not participate (but were still in the study), and five did not have data available at all three time points. In this study, we include all women for whom blood samples (n = 53) and dietary data (n = 56) were available at baseline and at the 12- and 36-mo follow-up periods.
Dietary supplements were not a component of this trial, and participants were particularly discouraged from using high dose micronutrient formulations that could interfere with the interpretation of the diet intervention results. However, ~20 women used ß-carotene supplementation at 1 y and 27 at 3 y postrandomization. Quantification of ß-carotene intake includes that obtained from ß-carotene supplements for those participants who used supplements containing the micronutrient.
The study intervention involved an intensive telephone counseling
regimen aimed at assisting participants to reach the following daily
dietary goals: five vegetable servings, 16 oz of fresh vegetable juice,
three fruit servings, 15% energy from fat, and 30 g of fiber. The
vegetable juice was included as a way to increase micronutrient intake
from food sources without the side effects of consuming too much fiber.
A serving of fruit or vegetable was defined as 0.5 cup of sliced or
chopped raw or cooked vegetables or fruit, 0.25 cup of dried fruit, one
medium piece of fresh fruit, 1 cup of raw green leafy vegetables, or
equivalent amounts provided in multi-ingredient foods. Three ounces
of vegetable juice were considered equivalent to one serving of
vegetables on the basis of an evaluation of the micronutrient content
(described below), thus vegetable juice could replace vegetable
servings. Therefore, quantified vegetable servings reported below are a
total of vegetable and vegetable juice consumption. The control group
was provided the National Cancer Institute (NCI) guidelines to consume
five fruits and vegetable servings a day and general public health
dietary guidelines (USDA 1990
). An analysis of dietary
change from baseline to 12 mo has been published previously
(Pierce et al. 1997
).
Participants provided fasting blood samples and other relevant information at scheduled clinic visits. Weight and height were measured at enrollment, 12 and 36 mo, and body mass index [BMI; weight (kg)/height (m2)]) was calculated. Follow-up clinic visits and dietary assessments were scheduled year-round and coincided with the participants randomization date. Procedures for this study were approved by the Human Subjects Committee of the University of California, San Diego, School of Medicine.
Dietary assessment.
Dietary intake was assessed by trained telephone interviewers, who
collected four 24-h dietary recalls on randomly selected days
stratified for weekend vs. weekdays over a 2-wk period. Dietary data
were collected and analyzed with the Nutrition Data System software
(University of Minnesota, Minneapolis, MN); nutrient analysis was
conducted with the University of Minnesota Database (Version 2.91, 1996, University of Minnesota,Minneapolis, MN). Dietary intakes of
carotenoids were computed using the USDA-NCI carotenoid food
composition database, which contains values for
- and ß-carotene,
ß-cryptoxanthin, lycopene and lutein plus zeaxanthin in >2240 fruits
and vegetables and multi-ingredient foods containing fruits and
vegetables (Chug-Ahuja et al. 1993
).
Plasma measurements.
Fasting blood samples were collected by venipuncture at baseline, 12
and 36 mo postrandomization. Samples were protected from light
throughout processing and handling. Samples collected to derive plasma
were obtained using EDTA-treated tubes, and separation of plasma
was accomplished with centrifugation at 2300 x g
at 4°C for 10 min. Samples were stored at -70°C until lipid
extraction and HPLC analysis. We were required to change laboratories
at the end of the 1st and 2nd y of the feasibility study. Therefore,
plasma carotenoids were separated and quantified using the HPLC methods
of Nierenberg and Nann (1992)
, Peng et al. (1994)
and Gamboa-Pinto et al. (1998)
. Accuracy
was assessed by periodic analysis of the National Institute of
Standards and Technology (NIST) Reference Material SRM 986:
Fat-Soluble Vitamins; the laboratories that provided the HPLC
analyses for this study participated in the NIST Micronutrients
Measurement Quality Assurance Program. Total plasma cholesterol was
determined with the Kodak Ektachem Analyzer system (Johnson & Johnson,
Rochester, NY) (Shirey 1985
).
Statistical analysis.
Log transformation of plasma carotenoid concentrations and carotenoid intake data was conducted to convert the data from a highly skewed distribution to an approximated Gaussian distribution. Plasma carotenoid concentrations were also adjusted for plasma cholesterol concentrations before analysis of these data. To account for variations in energy intake that could influence micronutrient consumption, dietary carotenoid consumption, before analysis, was energy adjusted by dividing the micronutrient consumption by the participants energy intake (the nutrient density method). Baseline BMI, carotenoid consumption, age, stage and ethnicity of these subjects (with data at all three time points) were compared with subjects not included in the analysis using an independent t test.
An independent samples t test was conducted to compare differences for dietary carotenoid consumption, plasma carotenoid concentrations, daily dietary intakes of vegetable and fruit servings, fiber, and percentage of energy from fat between the intervention and control groups at baseline, 12 and 36 mo. To reduce the variance due to the small sample size, repeated-measures ANOVA was also used to examine the differences within the intervention and control groups in plasma carotenoid concentrations at baseline, 12 and 36 mo. After observing an overall significant F-ratio for time in the repeated-measures ANOVA, we evaluated contrasts among the baseline, 12- and 36-mo values. Because three comparisons were made (baseline vs. 12 mo, baseline vs. 36 mo, and 12 mo vs. 36 mo), the Bonferroni method was used to adjust the nominal level of significance for these multiple comparisons (0.05/3 = 0.017). Pearson correlation coefficient analysis was conducted to examine associations between fruit and vegetable intakes and plasma carotenoid concentrations.
We used stepwise regression analysis to examine predictors of change in
plasma
-carotene, ß-carotene, lutein, lycopene and
ß-cryptoxanthin concentrations from baseline to 36 mo for the entire
group. This increased power and permitted observation of any
associations. The independent variables used in the models for
predicting change were as follows: change in dietary carotenoid intake,
change in BMI, age, change in plasma cholesterol concentration,
baseline plasma carotenoid concentrations and change in percentage of
energy from fat. Associations between the independent variables and the
outcome variable (change in plasma carotenoid concentration) produced
from the stepwise regression analysis are reported. All statistical
analysis was performed using the Statistical Analysis System (Version 6.12, 1998, SAS Institute,Cary,NC).
| RESULTS |
|---|
|
|
|---|
Table 1
summarizes data on vegetable (including vegetable juice), fruit, fat
and fiber intakes at baseline, 12 and 36 mo.
Independent t test analysis revealed that vegetable, fruit and fiber intakes were significantly higher at 12 mo for the intervention compared with the control group (P < 0.05). Also, vegetable intake was significantly higher at 36 mo for the intervention group. In addition, the percentage of energy from fat was significantly lower at 12 and 36 mo for the intervention group (P < 0.05).
|
-carotene and lutein at 36 mo compared with
the control groups (P < 0.05); in addition,
consumption of all carotenoids, except for lycopene, was significantly
higher at 12 mo for the intervention group.
|
-carotene concentration was significantly higher at 12 and
36 mo for the intervention compared with the control group
(P < 0.05), and plasma ß-carotene concentration was
significantly higher at 36 mo. Repeated-measures ANOVA revealed
that compared with baseline, the intervention group had significantly
higher plasma ß-carotene,
-carotene, lutein and lycopene
concentrations (P < 0.05) at 12 and 36 mo, whereas the
control group values did not differ significantly from baseline.
|
-carotene
(r = 0.30, P < 0.05) and ß-carotene
plasma concentrations (r = 0.33, P < 0.05) at 3 y postrandomization.
Predictors of change from baseline to 36 mo for plasma ß-carotene,
-carotene, lutein, lycopene and ß-cryptoxanthin concentrations for
the entire study sample were examined. The significance level used for
variables to enter the stepwise regression models was P
< 0.15. The stepwise regression model for change in plasma
ß-carotene revealed a significant inverse correlation with baseline
carotenoid concentrations (P < 0.05) and a positive
association with age. Similarly, change in plasma
-carotene was
significantly inversely related to baseline
-carotene concentrations
(P < 0.05). Change in plasma lutein concentration was
also significantly inversely related to baseline concentration
(P < 0.05), marginally inversely related to change in
BMI (P < 0.09) and positively correlated with change
in plasma cholesterol concentration (P < 0.09). Change
in circulating lycopene concentration was independently inversely
associated with baseline lycopene concentration (P < 0.05) and inversely marginally significantly associated with change in
BMI (P < 0.09). Finally, change in plasma
ß-cryptoxanthin concentration had an inverse significant association
with baseline ß-cryptoxanthin concentration (P < 0.05), a marginally positive association with change in plasma
cholesterol concentration (P < 0.09), a marginal
inverse association with change in BMI (P < 0.09) and
a negative relationship with age. Change in dietary micronutrient
intake and change in the percentage of energy from fat did not enter
the models at P < 0.15 and were not significantly
associated with changes in the plasma carotenoid concentrations from
baseline to 36 mo.
| DISCUSSION |
|---|
|
|
|---|
-carotene
and lutein at 3 y postrandomization and significantly higher
consumption of all carotenoids, except lycopene, at 1 y
postrandomization, compared with the control group. When comparing
circulating carotenoids between groups, at 36 mo, plasma
- and
ß-carotene concentrations remained significantly higher for the
intervention group. Also, all plasma carotenoid concentrations, except
for ß-cryptoxanthin, remained significantly higher compared with
baseline in the intervention group, whereas the control group showed no
significant changes from baseline. This suggests that, even if some
plasma concentrations were not significantly different between groups,
plasma carotenoid concentrations in the intervention group had
significantly increased at the time of the 3-y follow-up, whereas
the control group remained close to baseline levels. Analysis of plasma
carotenoid change revealed that change in BMI, change in plasma
cholesterol concentration and baseline plasma carotenoid concentrations
are independent predictors of change in plasma carotenoid
concentrations from baseline to 3 y. Overall, these results
indicate that making long-term dietary changes via increasing
vegetable and fruit intake can correspond with long-term changes in
plasma carotenoid concentrations.
Our findings of predictors of change in plasma carotenoids are
consistent with several previous studies. After adjusting for other
variables in the model, Ascherio et al. (1992)
found an
inverse association between BMI and plasma concentrations of
ß-carotene,
-carotene, lycopene, lutein and zeaxanthin in a
cross-sectional study; other studies have observed this inverse
relationship with ß-carotene (Nierenberg et al. 1989
,
Rock and Swendseid 1993
, Rock et al. 1997
, Stryker et al. 1988
),
-carotene and
ß-cryptoxanthin (Rock et al. 1997
). In addition, we
found that change in plasma cholesterol concentration was positively
associated with changes in plasma carotenoids (particularly
ß-cryptoxanthin and lutein plasma concentrations), an association
that has been observed in cross-sectional examinations
(Ascherio et al. 1992
, Brady et al. 1996
,
Clevidence and Bieri 1993
). The relationship between
change in plasma carotenoids with plasma cholesterol concentrations may
be explained by the transport of carotenoids by cholesterol-rich
lipoproteins in the plasma. The inverse association between age and
ß-carotene change observed in this study has also been noted in some
cross-sectional analyses (Brady et al. 1996
,
Nierenberg et al. 1989
), but not in others
(Ascherio et al. 1992
, Rock et al. 1997
).
A earlier study conducted by Nierenberg et al. (1991)
reported factors that influenced change in plasma ß-carotene
concentrations from baseline to 1 y after ß-carotene
supplementation. In that study, change in plasma ß-carotene
concentration was significantly related to baseline ß-carotene
concentration, but in the opposite direction. Results from other
studies, similar to the present findings, indicated an inverse
relationship between change in plasma ß-carotene concentration and
baseline concentrations in men (Wahlqvist et al. 1994
)
and in women (Rock et al. 1997
). In the study of
Nierenberg et al. (1991) change in plasma ß-carotene
concentration was inversely related to change in BMI (in females),
which parallels results of this study; however, this relationship was
observed only for changes in plasma lutein, lycopene and
ß-cryptoxanthin concentrations, and not for changes in plasma
ß-carotene concentration. The models predicting change in our study
explained 2154% of the variation, revealing that further
investigations must be conducted to find other factors that may further
contribute to change in plasma carotenoid concentrations.
In the study conducted by Rock et al. (1997)
, data
were obtained from a cohort similar to that of the present
investigation, but at different time points. We found some comparable
results when analyzing predictors of change from baseline to 3 y.
The present results, in agreement with the findings of Rock et al. (1997)
, revealed an inverse association with baseline
plasma concentrations and change from baseline to 36 mo for plasma
ß-carotene, lutein, lycopene and ß-cryptoxanthin. We also found
this association for change in plasma
-carotene concentration. In
this study, age was not related to plasma carotenoid change (except for
ß-carotene), but was inversely associated with change in plasma
ß-carotene,
-carotene, lutein and lycopene in the earlier report.
Although these results coincide to some extent, differences in sample
size, the addition of 36-mo data and differences in predictors used in
the models may account for some discrepant findings when examining
change in plasma carotenoid concentrations.
Changes in intakes of specific carotenoids were not correlated
with changes in plasma carotenoids in this study. Individual
differences in food content of carotenoids, including seasonal
variation, and differences in bioavailability from various food sources
may constrain the ability to find correlations between change in
carotenoid intakes and serum carotenoid concentrations
(Chug-Ahuja et al. 1993
, Mangels et al. 1993
).
We demonstrated that a twofold increase in vegetable servings
corresponded to nearly a twofold increase in plasma ß-carotene
concentration and an almost fourfold increase in plasma
-carotene
concentration at 3 y postrandomization in the intervention group.
We also found significant correlation between total fruit and vegetable
servings and both of these plasma carotenoids. Several
cross-sectional studies have reported associations between plasma
carotenoid concentrations and vegetable and fruit servings
(Campbell et al. 1994
, Polsinelli et al. 1998
); however, only one randomized trial has previously
reported an association between plasma carotenoid response to a high
vegetable and fruit diet at 3 mo (Le Marchand et al. 1994
).
From baseline to the end of y 1, ~25% of the women were no longer participating in the study; from y 1 to 3, another 20% were not included in the analysis (either due to recurrence or lack of participation). Therefore, the decrease in sample size may diminish power and ability to detect differences between the two groups. However, the rates of nonparticipation are nondifferential in both the intervention and control groups, thus eliminating bias due to differential loss to follow-up that could have altered the findings of this study.
In summary, these results suggest that carotenoids can be used as biomarkers of a high vegetable diet in women at risk of breast cancer recurrence participating in a randomized clinical trial. In addition, the results indicate that factors associated with plasma carotenoid response in cross-sectional examinations also predict plasma carotenoid change.
| FOOTNOTES |
|---|
2 Supported in part by an award from the Walton Family Foundation. ![]()
Manuscript received June 10, 1999. Initial review completed July 28, 1999. Revision accepted September 7, 1999.
| REFERENCES |
|---|
|
|
|---|
1. Adlercreutz H., Mousavi Y., Hockerstedt K. Diet and breast cancer. Acta Oncol 1992;31:175-181[Medline]
2. Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 1975;15:617-631[Medline]
3. Ascherio A., Stampfer M. J., Colditz G. A., Rimm E. B., Litin L., Willett W. C. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J. Nutr. 1992;122:1792-1801
4. Beahrs O., Henson D., Hutter R., Myers M. Staging for carcinoma of the breast. Manual for Staging of Cancer 3rd ed. 1988:145-150 J. B. Lippincott Philadelphia, PA.
5. Brady W. E., Mares-Perlman J. A., Bowen P., Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifesytle factors. J. Nutr. 1996;126:129-137
6. Campbell D. R., Gross M. D., Martini M. C., Granditis G. A., Slavin J. L., Potter J. D. Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol. Biomark. Prev. 1994;3:493-500[Abstract]
7. Chug-Ahuja J. K., Holden J. M., Forman M. R., Mangels A. R., Beecher G. R., Lanza E. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J. Am. Diet. Assoc. 1993;93:318-323[Medline]
8. Clevidence B. A., Bieri J. G. Association of plasma carotenoids with human plasma lipoprotein fractions. Methods Enzymol 1993;214:33-46[Medline]
9.
Gamboa-Pinto A. J., Rock C. L., Ferruzzi M. G., Schowinsky A. B., Schwartz S. J. Cervical tissue and plasma concentrations of
-carotene and ß-carotene are correlated. J. Nutr. 1998;128:1933-1936
10. Le Marchand L., Hankin J. H., Carter F. S., Essling C., Luffey D., Franke A. A., Wilkens L. R., Cooney R. V., Kolonel L.N. A pilot study on the use of plasma carotenoids and ascorbic acid as markers of compliance to a high fruit and vegetable dietary intervention. Cancer Epidemiol. Biomark. Prev. 1994;3:245-251[Abstract]
11. Mangels A. R., Holden J. M., Beecher G. R., Forman M. R., Lanza E. Carotenoid content of fruits and vegetables; an evaluation of analytic data. J. Am. Diet. Assoc. 1993;93:284-296[Medline]
12. Martini M. C., Campbell D. R., Gross M. D., Grandits G. A., Potter J. D., Slavin J. L. Plasma carotenoids as biomarkers of vegetable intake: the University of Minnesota Cancer Prevention Research Unit feeding studies. Cancer Epidemiol. Biomark. Prev. 1995;4:491-496[Abstract]
13.
Micozzi M. S., Brown E. D., Edwards B. K., Bieri J. G., Taylor P. R., Khachik F., Beecher G. R., Smith J. C. Plasma carotenoid response to chronic intake of selected foods and ß-carotene supplements in men. Am. J. Clin. Nutr. 1992;55:1120-1125
14.
Nierenberg D. W., Nann S. L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am. J. Clin. Nutr. 1992;56:417-426
15.
Nierenberg D. W., Stukel T. A., Baron J. A., Dain D. W., Greenberg E. R., & The Skin Cancer Prevention Study Group Determinants of plasma levels of ß-carotene and retinol. Am. J. Epidemiol. 1989;130:511-512
16.
Nierenberg D. W., Stukel T. A., Baron J. A., Dain B. J., Greenberg E. R., The Skin Cancer Prevention Study Group Determinants of increase in plasma concentration of ß-carotene after chronic oral supplementation. Am. J. Clin. Nutr. 1991;53:1443-1449
17. Olson J. A. Absorption, transport, and metabolism of carotenoids in humans. Pure Appl. Chem. 1994;66:1011-1016
18. Parker R. S. Bioavailability of carotenoids. Eur. J. Clin. Nutr. 1997;51(suppl. 1):S86-S90
19. Peng Y. M., Peng Y. S., Lin Y., Moon T., Roe D. J., Ritenbaugh C. Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans. Nutr. Cancer 1994;23:233-246
20. Pierce J. P., Faerber S., Wright F. A., Newman V., Flatt S. W., Kealey S., Rock C. L., Hryniuk W., Greenberg E. R. Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr. Cancer 1997;28:282-288[Medline]
21. Polsinelli M. L., Rock C. L., Henderson S. A., Drewnowski A. Plasma carotenoids as biomarkers of fruit and vegetable servings in women. J. Am. Diet. Assoc. 1998;98:194-196[Medline]
22. Rock C. L. Carotenoids: biology and treatment. Pharmacol. Ther. 1997;75:185-197[Medline]
23. Rock C. L., Flatt S. W., Wright F. A., Faerber S., Newman V., Kealey S., Pierce J. P. Responsiveness of carotenoids to a high vegetable diet intervention designed to prevent breast cancer recurrence. Cancer Epidemiol. Biomark. Prev. 1997;6:617-623[Abstract]
24.
Rock C. L., Swendseid M. E. Plasma ß-carotene response in humans after meals supplemented with dietary pectin. Am. J. Clin. Nutr. 1992;55:96-99
25. Rock C. L., Swendseid M. E. Plasma carotenoid levels in anorexia nervosa and in obese patients. Methods Enzymol 1993;214:116-123[Medline]
26. Rock C. L., Swendseid M. E., Jacob R. A., McKee R. W. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J. Nutr. 1992;122:96-100
27. Shirey T. L. Development of a layered-coating technology for clinical chemistry. Clin. Biochem. 1985;16:147-155
28. Steinmetz K. A., Potter J. D. Vegetables, fruits, and cancer prevention: a review. J. Am. Diet. Assoc. 1996;96:1027-1093[Medline]
29.
Stryker W. S., Kaplan L. A., Stein E. A., Stampfer M. J., Sober A., Willett W. C. The relation of diet, cigarette smoking, and alcohol consumption to plasma ß-carotene and
-tocopherol levels. Am. J. Epidemiol. 1988;127:283-296
30. U.S. Department of Agriculture, Human and Nutrition Information Service Good Sources of Nutrients 1990 USDA Hyattsville, MD.
31.
Wahlqvist M. L., Wattanapenpaiboon N., Macrae F. A., Lambert J. R., Maclennan R., Hsu-Hage B. H., Australian Polyp Prevention Project Investigators Changes in serum carotenoids in subjects with colorectal adenomas after 24 months of ß-carotene supplementation. Am. J. Clin. Nutr. 1994;60:936-943
32.
Yeum K. J., Booth S. L., Sadowski J. A., Liu C., Tang G., Krinsky N. I., Russell R. M. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am. J. Clin. Nutr. 1995;64:594-602
This article has been cited by other articles:
![]() |
W. Demark-Wahnefried, E. C. Clipp, I. M. Lipkus, D. Lobach, D. C. Snyder, R. Sloane, B. Peterson, J. M. Macri, C. L. Rock, C. M. McBride, et al. Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer Survivors J. Clin. Oncol., July 1, 2007; 25(19): 2709 - 2718. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Mikkelsen, S. F. Olsen, S. E. Rasmussen, and M. Osler Relative validity of fruit and vegetable intake estimated by the food frequency questionnaire used in the Danish National Birth Cohort Scand J Public Health, March 1, 2007; 35(2): 172 - 179. [Abstract] [PDF] |
||||
![]() |
M. M. Gaudet, J. A. Britton, G. C. Kabat, S. Steck-Scott, S. M. Eng, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, and M. D. Gammon Fruits, Vegetables, and Micronutrients in Relation to Breast Cancer Modified by Menopause and Hormone Receptor Status Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1485 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brevik, S. E. Rasmussen, C. A. Drevon, and L. F. Andersen Urinary Excretion of Flavonoids Reflects Even Small Changes in the Dietary Intake of Fruits and Vegetables Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 843 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Bogers, P. van Assema, A. D. M. Kester, K. R. Westerterp, and P. C. Dagnelie Reproducibility, Validity, and Responsiveness to Change of a Short Questionnaire for Measuring Fruit and Vegetable Intake Am. J. Epidemiol., May 1, 2004; 159(9): 900 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Mayne, B. Cartmel, H. Lin, T. Zheng, and W. J. Goodwin Jr Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers J. Am. Coll. Nutr., February 1, 2004; 23(1): 34 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rock, S. W. Flatt, C. A. Thomson, M. L. Stefanick, V. A. Newman, L. Jones, L. Natarajan, J. P. Pierce, R. J. Chang, and J. L. Witztum Plasma Triacylglycerol and HDL Cholesterol Concentrations Confirm Self-Reported Changes in Carbohydrate and Fat Intakes in Women in a Diet Intervention Trial J. Nutr., February 1, 2004; 134(2): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Kim, S. Sasazuki, S. Sasaki, S. Okubo, M. Hayashi, and S. Tsugane Effect of Five-Year Supplementation of Vitamin C on Serum Vitamin C Concentration and Consumption of Vegetables and Fruits in Middle-Aged Japanese: A Randomized Controlled Trial J. Am. Coll. Nutr., June 1, 2003; 22(3): 208 - 216. [Abstract] [Full Text] |
||||
![]() |
R. P. Bogers, P. C. Dagnelie, K. R. Westerterp, A. D. M. Kester, J. D. van Klaveren, A. Bast, and P. A. van den Brandt Using a Correction Factor to Correct for Overreporting in a Food-Frequency Questionnaire Does Not Improve Biomarker-Assessed Validity of Estimates for Fruit and Vegetable Consumption J. Nutr., April 1, 2003; 133(4): 1213 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Mayne Antioxidant Nutrients and Chronic Disease: Use of Biomarkers of Exposure and Oxidative Stress Status in Epidemiologic Research J. Nutr., March 1, 2003; 133(3): 933S - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rock and W. Demark-Wahnefried Can Lifestyle Modification Increase Survival in Women Diagnosed with Breast Cancer? J. Nutr., November 1, 2002; 132(11): 3504S - 3509. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S Ford, C. Gillespie, C. Ballew, A. Sowell, and D. M Mannino Serum carotenoid concentrations in US children and adolescents Am. J. Clinical Nutrition, October 1, 2002; 76(4): 818 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Terry, M. Jain, A. B Miller, G. R Howe, and T. E Rohan Dietary carotenoids and risk of breast cancer Am. J. Clinical Nutrition, October 1, 2002; 76(4): 883 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rock and W. Demark-Wahnefried Nutrition and Survival After the Diagnosis of Breast Cancer: A Review of the Evidence J. Clin. Oncol., August 1, 2002; 20(15): 3302 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Dixon, M. A. Winkleby, and K. L. Radimer Dietary Intakes and Serum Nutrients Differ between Adults from Food-Insufficient and Food-Sufficient Families: Third National Health and Nutrition Examination Survey, 1988-1994 J. Nutr., April 1, 2001; 131(4): 1232 - 1246. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||